Cited by 316Immune cells in cancerAcute Myeloid Leukemia ResearchHematopoietic Stem Cell Transplantation

The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.

Induction of myelodysplasia by myeloid-derived suppressor cells

Open access

Chen, Xianghong, Eksioglu, Erika A., Zhou, Junmin, Zhang, Ling, Djeu, Julie, Fortenbery, Nicole, Epling-Burnette, Pearlie, Van Bijnen, Sandra, Dolstra, Harry, Cannon, John, Youn, Je-in, Donatelli, Sarah S., Qin, Dahui, De Witte, Theo, Tao, Jianguo, Wang, Huaquan, Cheng, Pingyan, Gabrilovich, Dmitry I., List, Alan, Wei, Sheng·2013·Journal of Clinical Investigation

DOI 10.1172/jci67580PMC PMC3809779

Open this paper in CoChat — free account Open PDF

Abstract

Myelodysplastic syndromes (MDS) are age-dependent stem cell malignancies that share biological features of activated adaptive immune response and ineffective hematopoiesis. Here we report that myeloid-derived suppressor cells (MDSC), which are classically linked to immunosuppression, inflammation, and cancer, were markedly expanded in the bone marrow of MDS patients and played a pathogenetic role in the development of ineffective hematopoiesis. These clonally distinct MDSC overproduce hematopoietic suppressive cytokines and function as potent apoptotic effectors targeting autologous hematopoietic progenitors. Using multiple transfected cell models, we found that MDSC expansion is driven by the interaction of the proinflammatory molecule S100A9 with CD33. These 2 proteins formed a functional ligand/receptor pair that recruited components to CD33’s immunoreceptor tyrosine-based inhibition motif (ITIM), inducing secretion of the suppressive cytokines IL-10 and TGF-β by immature myeloid cells. S100A9 transgenic mice displayed bone marrow accumulation of MDSC accompanied by development of progressive multilineage cytopenias and cytological dysplasia. Importantly, early forced maturation of MDSC by either all-trans-retinoic acid treatment or active immunoreceptor tyrosine-based activation motif–bearing (ITAM-bearing) adapter protein (DAP12) interruption of CD33 signaling rescued the hematologic phenotype. These findings indicate that primary bone marrow expansion of MDSC driven by the S100A9/CD33 pathway perturbs hematopoiesis and contributes to the development of MDS.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci67580

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Self-citation
NK CELL RECOGNITION
Lanier, L. L. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115526 · Cited by 2,765
Siglecs and their roles in the immune system
Crocker, P. R., Paulson, J. C., & Varki, A. P. (2007) · Nature reviews. Immunology · doi:10.1038/nri2056 · Cited by 2,032
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
Ostrand‐Rosenberg, S., & Sinha, P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802740 · Cited by 1,777
Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
Youn, J., Nagaraj, S., Collazo, M. M., & Gabrilovich, D. I. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5791 · Cited by 1,645
Self-citation
Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock
Vogl, T., Tenbrock, K., Ludwig, S., Leukert, N., Ehrhardt, C., van Zoelen, M. A. D., Nacken, W., Foell, D., van der Poll, T., Sorg, C., et al. (2007) · Nature Medicine · doi:10.1038/nm1638 · Cited by 1,418 · cited 2×
“Given our findings that S100A9 triggers CD33/Siglec 3 signaling and is involved in MDSC activation (17, 18, 37), we generated S100A9Tg mice to study MDSC-associated inflammation (37).”
Immune Inhibitory Receptors
Ravetch, J. V., & Lanier, L. L. (2000) · Science · doi:10.1126/science.290.5489.84 · Cited by 1,278
Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia
Raaijmakers, M. H. G. P., Mukherjee, S., Guo, S., Zhang, S., Kobayashi, T., Schoonmaker, J. A., Ebert, B. L., Al-Shahrour, F., Hasserjian, R. P., Scadden, E. O., et al. (2010) · Nature · doi:10.1038/nature08851 · Cited by 1,115
Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells
Lanier, L. L., Corliss, B. C., Wu, J., Leong, C. C., & Phillips, J. H. (1998) · Nature · doi:10.1038/35642 · Cited by 907
Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein
Cheng, P., Corzo, C. A., Luetteke, N., Yu, B., Nagaraj, S., Bui, M. M., Ortiz, M. L., Nacken, W. K. F., Sorg, C., Vogl, T., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080132 · Cited by 904
Self-citation
The endogenous Toll–like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer
Ehrchen, J. M., Sunderkötter, C. H., Foell, D., Vogl, T., & Roth, J. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.1008647 · Cited by 869
Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotype
Starczynowski, D. T., Kuchenbauer, F., Argiropoulos, B., Sung, S., Morin, R., Muranyi, A., Hirst, M., Hogge, D., Marra, M., Wells, R. A., et al. (2010) · Nature Medicine · doi:10.1038/nm.2054 · Cited by 577
All-trans-Retinoic Acid Improves Differentiation of Myeloid Cells and Immune Response in Cancer Patients
Mirza, N. N., Fishman, M., Fricke, I., Dunn, M. W., Neuger, A. M., Frost, T. J., Lush, R. M., Antonia, S. J., & Gabrilovich, D. I. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1690 · Cited by 566
Self-citation
Clonal analysis reveals multiple functional defects of aged murine hematopoietic stem cells
Dykstra, B., Olthof, S., Schreuder, J., Ritsema, M., & de Haan, G. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20111490 · Cited by 494 · cited 2×
“…indicate that TRAF6 is essential for survival and proliferation of MDS HSPC (11) and sustained TLR activation skews their commitment toward the myeloid lineage while suppressing osteoblast differentiation (12, 13), analogous to the senescence-dependent changes observed with normal aging (14).”
Cutting Edge: Inhibition of TLR and FcR Responses in Macrophages by Triggering Receptor Expressed on Myeloid Cells (TREM)-2 and DAP12
Hamerman, J. A., Jarjoura, J. R., Humphrey, M. B., Nakamura, M. C., Seaman, W. E., & Lanier, L. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2051 · Cited by 440
Mechanism of All- Trans Retinoic Acid Effect on Tumor-Associated Myeloid-Derived Suppressor Cells
Nefedova, Y., Fishman, M., Sherman, S., Wang, X., Beg, A. A., & Gabrilovich, D. I. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2593 · Cited by 428
Self-citation
Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes [see comments]
Raza, A., Gezer, S., Mundle, S. D., Gao, X., Alvi, S., Borok, R. Z., Rifkin, S., Iftikhar, A., Shetty, V., & Parcharidou, A. (1995) · Blood · doi:10.1182/blood.v86.1.268.bloodjournal861268 · Cited by 424
Demand-adapted regulation of early hematopoiesis in infection and inflammation
Takizawa, H., Boettcher, S., & Manz, M. G. (2012) · Blood · doi:10.1182/blood-2011-12-380113 · Cited by 420
Role Of Immature Myeloid Cells in Mechanisms of Immune Evasion In Cancer
Kusmartsev, S. A., & Gabrilovich, D. I. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-005-0048-z · Cited by 348
Self-citation
Loss of S100A9 (MRP14) Results in Reduced Interleukin-8-Induced CD11b Surface Expression, a Polarized Microfilament System, and Diminished Responsiveness to Chemoattractants In Vitro
Manitz, M., Horst, B. A. J., Seeliger, S., Strey, A., Skryabin, B., Gunzer, M., Frings, W., Schönlau, F., Roth, J., Sorg, C., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.3.1034-1043.2003 · Cited by 343
Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes
Bellamy, W. T., Richter, L. C., Sirjani, D., Roxas, C., Glinsmann‐Gibson, B., Frutiger, Y. M., Grogan, T. M., & List, A. F. (2001) · Blood · doi:10.1182/blood.v97.5.1427 · Cited by 338
Self-citation
Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML
Gondek, L. P., Tiu, R. V., O’Keefe, C. L., Sekeres, M. A., Theil, K. S., & Maciejewski, J. P. (2007) · Blood · doi:10.1182/blood-2007-05-092304 · Cited by 318
Inflammatory cell infiltration of tumors: Jekyll or Hyde
Talmadge, J. E., Donkor, M. K., & Scholar, E. M. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9072-0 · Cited by 312
Tumor Necrosis Factor-α Blocks Differentiation and Enhances Suppressive Activity of Immature Myeloid Cells during Chronic Inflammation
Sade-Feldman, M., Kanterman, J., Ish‐Shalom, E., Elnekave, M., Horwitz, E. P., & Baniyash, M. (2013) · Immunity · doi:10.1016/j.immuni.2013.02.007 · Cited by 306
Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis
Nutku, E., Aizawa, H., Hudson, S. A., & Bochner, B. S. (2003) · Blood · doi:10.1182/blood-2002-10-3058 · Cited by 306
Chronic Immune Stimulation Might Act As a Trigger for the Development of Acute Myeloid Leukemia or Myelodysplastic Syndromes
Kristinsson, S. Y., Björkholm, M., Hultcrantz, M. L., Derolf, Å. R., Landgren, O., & Goldin, L. R. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.8540 · Cited by 289
Pathways Mediating the Expansion and Immunosuppressive Activity of Myeloid-Derived Suppressor Cells and Their Relevance to Cancer Therapy
Talmadge, J. E. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0182 · Cited by 286
Activating and inhibitory functions of DAP12
Turnbull, I. R., & Colonna, M. (2007) · Nature Reviews Immunology · doi:10.1038/nri2014 · Cited by 273
Siglec-H is an IPC-specific receptor that modulates type I IFN secretion through DAP12
Blasius, A. L., Cella, M., Maldonado, J., Takai, T., & Colonna, M. (2005) · Blood · doi:10.1182/blood-2005-09-3746 · Cited by 258
Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow
Hofmann, W., de Vos, S., Komor, M., Hoelzer, D. F., Wachsman, W., & Koeffler, H. P. (2002) · Blood · doi:10.1182/blood.v100.10.3553 · Cited by 235
Blood CD33(+)HLA-DR(−) myeloid-derived suppressor cells are increased with age and a history of cancer
Verschoor, C. P., Johnstone, J., Millar, J., Dorrington, M. G., Habibagahi, M., Lelic, A., Loeb, M., Bramson, J. L., & Bowdish, D. M. E. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0912461 · Cited by 235
Cloning and expression of two human genes encoding calcium-binding proteins that are regulated during myeloid differentiation.
Lagasse, E., & Clerc, R. G. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.6.2402 · Cited by 219
Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2
Paul, S. P., Taylor, L. S., Stansbury, E. K., & McVicar, D. W. (2000) · Blood · doi:10.1182/blood.v96.2.483 · Cited by 204
Negative Regulation of T Cell Receptor Signaling by Siglec-7 (p70/AIRM) and Siglec-9
Ikehara, Y., Ikehara, S. K., & Paulson, J. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403538200 · Cited by 203
Targeting IRAK1 as a therapeutic approach for myelodysplastic syndrome
Rhyasen, G. W., Bolanos, L., Fang, J., Jerez, A., Wunderlich, M., Rigolino, C., Mathews, L., Ferrer, M., Southall, N., Guha, R., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.05.006 · Cited by 199
A critical role for phosphatase haplodeficiency in the selective suppression of deletion 5q MDS by lenalidomide
Sheng, W., Chen, X., Rocha, K., Epling‐Burnette, P. K., Djeu, J. Y., Liu, Q., Byrd, J. C., Sokol, L., Lawrence, N., Pireddu, R., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811267106 · Cited by 195
Self-citation
Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma
Kapanadze, T. G., Gamrekelashvili, J., Ma, C., Chan, C., Zhao, F., Hewitt, S. M., Zender, L., Kapoor, V., Felsher, D. W., Manns, M. P., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.06.010 · Cited by 186
The Membrane-Proximal Immunoreceptor Tyrosine-Based Inhibitory Motif Is Critical for the Inhibitory Signaling Mediated by Siglecs-7 and -9, CD33-Related Siglecs Expressed on Human Monocytes and NK Cells
Avril, T., Floyd, H., Lopez, F., Vivier, É., & Crocker, P. R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.11.6841 · Cited by 176
Discovery of Siglec‐14, a novel sialic acid receptor undergoing concerted evolution with Siglec‐5 in primates
Angata, T., Hayakawa, T., Yamanaka, M., Varki, A. P., & Nakamura, M. (2006) · The FASEB Journal · doi:10.1096/fj.06-5800com · Cited by 174
Basic and Clinical Immunology of Siglecs
von Gunten, S., & Bochner, B. S. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1443.011 · Cited by 167
Specific lipid recognition is a general feature of CD300 and TREM molecules
Cannon, J. P., O’Driscoll, M., & Litman, G. W. (2011) · Immunogenetics · doi:10.1007/s00251-011-0562-4 · Cited by 165
Self-citation
MRP8/MRP14 impairs endothelial integrity and induces a caspase-dependent and -independent cell death program
Viemann, D., Barczyk, K., Vogl, T., Fischer, U., Sunderkötter, C. H., Schulze‐Osthoff, K., & Roth, J. (2006) · Blood · doi:10.1182/blood-2006-08-040444 · Cited by 144
Constitutive repressor activity of CD33 on human monocytes requires sialic acid recognition and phosphoinositide 3‐kinase‐mediated intracellular signaling
Lajaunias, F., Dayer, J., & Chizzolini, C. (2004) · European Journal of Immunology · doi:10.1002/eji.200425273 · Cited by 143
Novel insights into the biology of myelodysplastic syndromes: excessive apoptosis and the role of cytokines.
Raza (1996) · International Journal of Hematology · doi:10.1016/0925-5710(96)00455-0 · Cited by 141
Toll-like Receptor-4 Is Up-Regulated in Hematopoietic Progenitor Cells and Contributes to Increased Apoptosis in Myelodysplastic Syndromes
Maratheftis, C. I., Andreakos, E., Moutsopoulos, H. Μ., & Voulgarelis, M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2108 · Cited by 140
Quick sex determination of mouse fetuses
Lambert, J., Benoit, B. O., Colvin, G. A., Carlson, J. E., Delville, Y., & Quesenberry, P. J. (2000) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(99)00157-0 · Cited by 139
Molecular mechanisms of the inhibitory effect of lipopolysaccharide (LPS) on osteoblast differentiation
Bandow, K., Maeda‐Iino, A., Kakimoto, K., Kusuyama, J., Shamoto, M., Ohnishi, T., & Matsuguchi, T. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.10.103 · Cited by 132
The TLR1/2 agonist PAM3CSK4 instructs commitment of human hematopoietic stem cells to a myeloid cell fate
Luca, K. D., Frances-Duvert, V., Asensio, M.-J., Ihsani, R., Debien, E., Taillardet, M., Verhoeyen, E., Bella, C., Lantheaume, S., Genestier, L., et al. (2009) · Leukemia · doi:10.1038/leu.2009.155 · Cited by 129
Cytotoxic effects of bortezomib in myelodysplastic syndrome/acute myeloid leukemia depend on autophagy-mediated lysosomal degradation of TRAF6 and repression of PSMA1
Fang, J., Rhyasen, G. W., Bolanos, L. C., Rasch, C., Varney, M. E., Wunderlich, M., Goyama, S., Jansen, G., Cloos, J. J., Rigolino, C., et al. (2012) · Blood · doi:10.1182/blood-2012-02-407999 · Cited by 109
High-resolution whole genome tiling path array CGH analysis of CD34+ cells from patients with low-risk myelodysplastic syndromes reveals cryptic copy number alterations and predicts overall and leukemia-free survival
Starczynowski, D. T., Vercauteren, S., Telenius, A., Sung, S., Tohyama, K., Brooks-Wilson, A. R., Spinelli, J. J., Eaves, C. J., Eaves, A. C., Horsman, D. E., et al. (2008) · Blood · doi:10.1182/blood-2007-11-122028 · Cited by 101
Sampling and signaling in plasmacytoid dendritic cells: the potential roles of Siglec-H
Blasius, A. L., & Colonna, M. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.04.005 · Cited by 96
Biological Significance of Proliferation, Apoptosis, Cytokines, and Monocyte/Macrophage Cells in Bone Marrow Biopsies of 145 Patients With Myelodysplastic Syndrome
Allampallam, K., Shetty, V. T., Mundle, S. D., Dutt, D., Kravitz, H. M., Reddy, P. L., Alvi, S., Galili, N., Saberwal, G. S., Anthwal, S., et al. (2002) · International Journal of Hematology · doi:10.1007/bf02982044 · Cited by 88
Intramedullary apoptosis of hematopoietic cells in myelodysplastic syndrome patients can be massive: apoptotic cells recovered from high-density fraction of bone marrow aspirates
Shetty, V. T., Hussaini, S., Broady-Robinson, L., Allampallam, K., Mundle, S. D., Borok, R. Z., Broderick, E., Mazzoran, L., Zorat, F., & Raza, A. (2000) · Blood · doi:10.1182/blood.v96.4.1388 · Cited by 79
Molecular Cloning of MIS, a Myeloid Inhibitory Siglec, That Binds Protein-tyrosine Phosphatases SHP-1 and SHP-2
Ulyanova, T., Shah, D. D., & Thomas, M. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011650200 · Cited by 59
An Improved Harvest andin VitroExpansion Protocol for Murine Bone Marrow-Derived Mesenchymal Stem Cells
Xu, S., Becker, A. D., Camp, B. V., Vanderkerken, K., & Riet, I. V. (2010) · BioMed Research International · doi:10.1155/2010/105940 · Cited by 59
Reprogramming of human postmitotic neutrophils into macrophages by growth factors
Araki, H., Katayama, N., Yamashita, Y., Mano, H., Fujieda, A., Usui, E., Mitani, H., Ohishi, K., Nishii, K., Masuya, M., et al. (2004) · Blood · doi:10.1182/blood-2003-08-2742 · Cited by 54
Tumour necrosis factor‐induced gene expression in human marrow stroma: clues to the pathophysiology of MDS?
Stirewalt, D. L., Mhyre, A. J., Marcondes, M., Pogosova‐Agadjanyan, E. L., Abbasi, N., Radich, J. P., & Deeg, H. J. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06923.x · Cited by 52
A critical role for DAP10 and DAP12 in CD8+ T cell–mediated tissue damage in large granular lymphocyte leukemia
Chen, X., Bai, F., Sokol, L., Zhou, J., Ren, A., Painter, J. S., Liu, J., Sallman, D. A., Chen, Y. A., Yoder, J. A., et al. (2008) · Blood · doi:10.1182/blood-2008-07-168245 · Cited by 48
Self-citation
A Bony Fish Immunological Receptor of the NITR Multigene Family Mediates Allogeneic Recognition
Cannon, J. P., Haire, R. N., Magis, A. T., Eason, D. D., Winfrey, K. N., Prada, J. A. H., Bailey, K. M., Jakoncic, J., Litman, G. W., & Ostrov, D. A. (2008) · Immunity · doi:10.1016/j.immuni.2008.05.018 · Cited by 48
Self-citation
Innate Immune Signaling in the Myelodysplastic Syndromes
Starczynowski, D. T., & Karsan, A. (2010) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2010.02.008 · Cited by 47
Inhibition of p38α MAPK disrupts the pathological loop of proinflammatory factor production in the myelodysplastic syndrome bone marrow microenvironment
Navas, T. A., Zhou, L., Estes, M. L., Haghnazari, E., Nguyen, A. N., Mo, Y., Pahanish, P., Mohindru, M., Cao, T. C., Higgins, L. S., et al. (2008) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190802322919 · Cited by 33
Self-citation
Chimerism Analysis in Sex-Mismatched Murine Transplantation Using Quantitative Real-Time PCR
Byrne, P., Huang, W., Wallace, V. M., Shean, M. K., Zhang, Z., Zhong, Q., Theodossiou, C., Blakesley, H. L., Kolls, J. K., & Schwarzenberger, P. O. (2002) · BioTechniques · doi:10.2144/02322st01 · Cited by 24
Construction, Expression, and Purification of Chimeric Protein Reagents Based on Immunoglobulin Fc Regions
Cannon, J. P., O’Driscoll, M., & Litman, G. W. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-139-0_4 · Cited by 12
Self-citation

Flagged first, then by citations

Research works printed but not linked: 3

Kapanadze, 2013, J Hepatol., pii, S0168-8278(13)00421-2
Xu, 2010, J Biomed Biotechnol., 2010, 105940
Ioachim HL Medeiros LJ Cytopathology. In: Iochimâ€™s Lymph Node Pathology. 4th ed. Philadelphia, Pennsylvania, USA: Wolters Kluwer/Lippincott Williams &Wilkins; 2008 21 22

Sorted by citations

Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19
Silvin, A., Chapuis, N., Dunsmore, G., Goubet, A.-G., Dubuisson, A., Derosa, L., Almire, C., Hénon, C., Kosmider, O., Droin, N., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.002 · Cited by 834
Calprotectin: from biomarker to biological function
Jukic, A., Bakiri, L., Wagner, E. F., Tilg, H., & Adolph, T. E. (2021) · Gut · doi:10.1136/gutjnl-2021-324855 · Cited by 500
Myeloid-derived suppressor cells in cancer and cancer therapy
Lasser, S., Kurt, F. G. Ö., Arkhypov, I., Utikal, J. S., & Umansky, V. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00846-y · Cited by 523
Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy
Wu, Y., Yi, M., Niu, M., Mei, Q., & Wu, K. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01657-y · Cited by 475
The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype
Basiorka, A. A., McGraw, K. L., Eksioglu, E. A., Chen, X., Johnson, J., Zhang, L., Zhang, Q., Irvine, B. A., Cluzeau, T., Sallman, D. A., et al. (2016) · Blood · doi:10.1182/blood-2016-07-730556 · Cited by 367
Self-citation

See all 316

Authors: Chen, X., Eksioglu, E. A., Zhou, J., Zhang, L., Djeu, J., Fortenbery, N., Epling-Burnette, P., Van Bijnen, S., Dolstra, H., Cannon, J., Youn, J.-I., Donatelli, S. S., Qin, D., De Witte, T., Tao, J., Wang, H., Cheng, P., Gabrilovich, D. I., List, A., & Wei, S.
Affiliations: Moffitt Cancer Center (US)
Radboud University Medical Center (NL)
University of South Florida (US)
Corresponding author: Wei, Sheng
ORCID: Chen, Xianghong
Eksioglu, Erika A.
Zhou, Junmin
Zhang, Ling
Dolstra, Harry
Qin, Dahui
Tao, Jianguo
Wang, Huaquan
Cheng, Pingyan
Gabrilovich, Dmitry I.
List, Alan
Wei, Sheng
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 2013-10-15
Volume: 123
Issue: 11
Pages: 4595-4611
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci67580
PMC: PMC3809779
OpenAlex: W2111063688
Cited by: 316
References: 63
Citations by year: 2026: 17 · 2025: 18 · 2024: 19 · 2023: 28 · 2022: 31 · 2021: 43 · 2020: 30 · 2019: 26 · 2018: 23 · 2017: 25 · 2016: 30 · 2015: 17 · 2014: 9
FWCI: 10.33
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Radboud Repository (Radboud University) (submittedVersion, other-oa)
Radboud Repository (Radboud University) (submittedVersion)
Funders: National Institutes of Health (AI056213)
National Cancer Institute (T32CA115308, R01CA131076, R01CA100062, P30CA076292)
National Institute of Allergy and Infectious Diseases (AI056213, R01AI056213)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
Keywords: myelodysplastic syndrome, myeloid-derived suppressor cells, ineffective hematopoiesis, S100A9, CD33, immunoreceptor tyrosine-based inhibition motif, ITAM, DAP12, IL-10, TGF-beta, bone marrow, all-trans retinoic acid, transgenic mice
MeSH terms: Animals, Disease Models, Animal, Female, Hematopoiesis, HLA-DR Antigens, Humans, Ligands, Male, Mice, Transgenic, Myelodysplastic Syndromes, Signal Transduction, Mice, Knockout, Adoptive Transfer, Myeloid Cells, Calgranulin A, Calgranulin B, Mice, Cellular Microenvironment, Sialic Acid Binding Ig-like Lectin 3

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Induction of myelodysplasia by myeloid-derived suppressor cells

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks